Cargando…
Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic eval...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963561/ https://www.ncbi.nlm.nih.gov/pubmed/31569624 http://dx.doi.org/10.3390/antibiotics8040166 |
_version_ | 1783488308442038272 |
---|---|
author | Holmes, Emily A. F. Hughes, Dyfrig A. |
author_facet | Holmes, Emily A. F. Hughes, Dyfrig A. |
author_sort | Holmes, Emily A. F. |
collection | PubMed |
description | The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic evaluations of health care interventions therefore need to consider the short-term costs of interventions, to gain future benefits. This represents a challenge for health economists, not only in terms of the most appropriate methods for evaluation, but also in attributing the potential budget impact over time and considering health impacts on future populations. This commentary discusses the challenge of accurately capturing the cost-effectiveness of health care interventions aimed at tackling antimicrobial resistance. We reflect on methods to capture and incorporate the costs and health outcomes associated with antimicrobial resistance, the appropriateness of the quality-adjusted-life year (QALY), individual time preferences, and perspectives in economic evaluation. |
format | Online Article Text |
id | pubmed-6963561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69635612020-01-30 Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance Holmes, Emily A. F. Hughes, Dyfrig A. Antibiotics (Basel) Commentary The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic evaluations of health care interventions therefore need to consider the short-term costs of interventions, to gain future benefits. This represents a challenge for health economists, not only in terms of the most appropriate methods for evaluation, but also in attributing the potential budget impact over time and considering health impacts on future populations. This commentary discusses the challenge of accurately capturing the cost-effectiveness of health care interventions aimed at tackling antimicrobial resistance. We reflect on methods to capture and incorporate the costs and health outcomes associated with antimicrobial resistance, the appropriateness of the quality-adjusted-life year (QALY), individual time preferences, and perspectives in economic evaluation. MDPI 2019-09-27 /pmc/articles/PMC6963561/ /pubmed/31569624 http://dx.doi.org/10.3390/antibiotics8040166 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Holmes, Emily A. F. Hughes, Dyfrig A. Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
title | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
title_full | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
title_fullStr | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
title_full_unstemmed | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
title_short | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
title_sort | challenges for economic evaluation of health care strategies to contain antimicrobial resistance |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963561/ https://www.ncbi.nlm.nih.gov/pubmed/31569624 http://dx.doi.org/10.3390/antibiotics8040166 |
work_keys_str_mv | AT holmesemilyaf challengesforeconomicevaluationofhealthcarestrategiestocontainantimicrobialresistance AT hughesdyfriga challengesforeconomicevaluationofhealthcarestrategiestocontainantimicrobialresistance |